AspenBio Pharma, Inc.·4

Dec 13, 6:35 PM ET

Hurd Donald R 4

4 · AspenBio Pharma, Inc. · Filed Dec 13, 2012

Insider Transaction Report

Form 4
Period: 2012-12-11
Hurd Donald R
SVP, Chief Commerical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-12-11+40,00040,000 total
    Exercise: $2.10Exp: 2012-12-11Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]The option to purchase 40,000 shares of common stock shall become exercisable in full on December 11, 2013.

Documents

1 file
  • 4
    appy_hurd4.xmlPrimary

    OWNERSHIP DOCUMENT